ARCHIVES

Gene Variant Associated With 44 Percent Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

NCI Adds $700,000 to CCOP Budget, Makes Four New Awards

June 9, 1989

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003